Replies to post #230584 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

PW

Let's hope when the time comes for the FDA to rule on Biogen's Adu, it has enough info on 2-73 that it may perform a comparison of the two drugs as to which helps sufferers more and provides benefits to sufferers and the families thereof ... and it has enough courage to make that comparison public for all to see and examine.

This might be a little "out of the box" thinking for the FDA, but isn't that what it claims it is shooting for in its new wave of reviewing

This juncture is what dr. Peter Senge ("5th Discipline")would define as a very high leverage opportunity.